Evidence map›Paper›PMID 36966134›Full record

ArticleNature communications2023

Lacking mechanistic disease definitions and corresponding association data hamper progress in network medicine and beyond.

Sepideh Sadegh, James Skelton, Elisa Anastasi, Andreas Maier, Klaudia Adamowicz, Anna Möller, Nils M Kriege, Jaanika Kronberg, Toomas Haller, Tim Kacprowski and 3 more

Full text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. A Multi-Dimensional Approach to Map Disease Relationships Challenges Classical Disease Views.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sepideh SadeghChair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-4851-8848
James SkeltonSchool of Computing, Newcastle University, Newcastle upon Tyne, UK.
Elisa AnastasiSchool of Computing, Newcastle University, Newcastle upon Tyne, UK.
Andreas MaierInstitute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0003-4408-0068
Klaudia AdamowiczInstitute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
Anna MöllerBiomedical Network Science Lab, Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0001-7517-8549
Nils M KriegeFaculty of Computer Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-2645-947X
Jaanika KronbergEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0003-2362-656X
Toomas HallerEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Tim KacprowskiDivision Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School, Braunschweig, Germany.ORCID http://orcid.org/0000-0002-5393-2413
Anil WipatSchool of Computing, Newcastle University, Newcastle upon Tyne, UK.
Jan BaumbachInstitute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0002-0282-0462
David B BlumenthalBiomedical Network Science Lab, Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. david.b.blumenthal@fau.de.ORCID http://orcid.org/0000-0001-8651-750X

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 777111
6 · The paper itself

Abstract

A long-term objective of network medicine is to replace our current, mainly phenotype-based disease definitions by subtypes of health conditions corresponding to distinct pathomechanisms. For this, molecular and health data are modeled as networks and are mined for pathomechanisms. However, many such studies rely on large-scale disease association data where diseases are annotated using the very phenotype-based disease definitions the network medicine field aims to overcome. This raises the question to which extent the biases mechanistically inadequate disease annotations introduce in disease association data distort the results of studies which use such data for pathomechanism mining. We address this question using global- and local-scale analyses of networks constructed from disease association data of various types. Our results indicate that large-scale disease association data should be used with care for pathomechanism mining and that analyses of such data should be accompanied by close-up analyses of molecular data for well-characterized patient cohorts.

Identifiers

PMID36966134
PMCPMC10039912

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read18
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.